A tumor-pH-responsive phthalocyanine as activatable type I photosensitizer for improved photodynamic immunotherapy
{{output}}
The development of a simple drug formulation capable of achieving both activatable type I photoreaction and tumor-responsive release of immunomodulator is crucial for advancing photodynamic immunotherapy (PDIT). Herein, we present a nanostructured photosensiti... ...
